CLYM FY 2024 Earnings — Climb Bio, Inc. Revenue & Financial Results | Market Cap Arena

CLYMClimb Bio, Inc.

$522M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$82M

Net Income

-$74M

EPS (Diluted)

$-1.53

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$217M

Total Liabilities

$5M

Stockholders' Equity

$212M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$82M	-$40M	-103.6%
Net Income	-$74M	-$35M	-110.4%